Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ganmao Shuangjie Granules is a traditional Chinese medicine (TCM) formulation used primarily for the treatment of influenza and common cold symptoms. Its TCM actions include "relieving exterior syndrome and dispelling cold," "clearing heat from the lung," "detoxifying," and "benefiting the throat." It is indicated for conditions such as wind-cold type common cold, influenza, acute bronchitis, early-stage pneumonia, and other syndromes characterized by fever, chills without sweating, headache, cough with yellow sputum or sore throat. The granule form allows for oral administration. Clinical studies have evaluated its efficacy and safety in treating influenza-like illnesses[1][3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ganmao Shuangjie Granules.